Amphiregulin enhances cardiac fibrosis and aggravates cardiac dysfunction in mice with experimental myocardial infarction partly through activating EGFR-dependent pathway

• Published in: Basic research in cardiology Vol. 113; no. 2; pp. 12 - 18
• Main Authors: Liu, Liang, Jin, Xian, Hu, Cui-Fen, Zhang, Ya-Ping, Zhou, Zhong'e, Li, Rong, Shen, Cheng-Xing
• Format: Journal Article
• Language: English
• Published: Germany Springer Nature B.V 01-03-2018
• Subjects: AKT protein; Amphiregulin; Amphiregulin - genetics; Amphiregulin - metabolism; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Collagen - metabolism; Disease Models, Animal; Epidermal growth factor; Epidermal growth factor receptors; ErbB Receptors - genetics; ErbB Receptors - metabolism; Fibroblasts; Fibroblasts - metabolism; Fibroblasts - pathology; Fibrosis; Gene expression; Genes; Heart attacks; Heart diseases; Heart rate; Macrophages; Macrophages - metabolism; Macrophages - pathology; Male; Mice; Mice, Inbred C57BL; Migration; Myocardial infarction; Myocardial Infarction - genetics; Myocardial Infarction - metabolism; Myocardial Infarction - pathology; Myocardial Infarction - physiopathology; Myocardium - metabolism; Myocardium - pathology; Myocytes, Cardiac - metabolism; Myocytes, Cardiac - pathology; Organs; Pathogenesis; RNA Interference; RNA, Small Interfering - genetics; RNA, Small Interfering - metabolism; Rodents; Secretion; Signal Transduction; Ventricle; Ventricular Function, Left - genetics; Ventricular Remodeling - genetics; EGFR pathway; Myocardial infarction; Cardiac fibrosis; Amphiregulin
• ISSN: 0300-8428; 1435-1803
• DOI: 10.1007/s00395-018-0669-y

Cardiac fibrosis (CF), a main process of ventricular remodeling after myocardial infarction (MI), plays a crucial role in the pathogenesis of heart failure (HF) post-MI. It is known that amphiregulin (AR) is involved in fibrosis of several organs. However, the expression of AR and its role post-MI are yet to be determined. This study aimed to investigate the impact of AR on CF post-MI and related mechanisms. Significantly upregulated AR expression was evidenced in the infarct border zone of MI mice in vivo and the AR secretion was enhanced in macrophages, but not in cardiac fibroblasts. In vitro, treatment with AR increased cardiac fibroblast migration, proliferation and collagen synthesis, and upregulated the expression of epidermal growth factor receptor (EGFR) and the downstream genes such as Akt, ERK1/2 and Samd2/3 on cardiac fibroblasts. All these effects could be abrogated by pretreatment with a specific EGFR inhibitor. To verify the functions of AR in MI hearts, lentivirus-AR-shRNA and negative control vectors were delivered into the infarct border zone. After 28 days, knock-down of AR increased the survival rate and improved cardiac function, while decreasing the extent of myocardial fibrosis of MI mice. Moreover, EGFR and the downstream genes were significantly downregulated in lentivirus-AR-shRNA treated MI mice. Our results thus indicate that AR plays an important role in promoting CF after MI partly though activating the EGFR pathway. Targeting AR might be a novel therapeutic option for attenuating CF and improve cardiac function after MI.